CD274 and cancer: Although 43% of patients in Abed et al. 2022 express PD-L1 in ≥50% of cancer tissue [12] compared to 19% in the present cohort, this might have no influence on our findings, as tumour PD-L1 is not reported to be associated with the development of irAEs.